Estados financieros detallados de Dare Bioscience, Inc. (DARE): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Márgenes de los últimos 12 meses: margen bruto -89.5%, margen operativo -8.1%, margen neto -8.0%.
Al precio actual de $0.73, DARE presenta beneficios negativos (P/E no significativo) y un ROE del -7.48%. La capitalización bursátil es de $11M.
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | $766000 | 0 | 0 | 0 | 0 | 0 | $10.0M | $2.8M | $9784 | $1.0M |
| Coste de Ventas | $400000 | 0 | $625000 | $11137 | $83333 | $100000 | $30.1M | $21.6M | $14.3M | $2.4M |
| Beneficio Bruto | $366000 | 0 | -$2440 | -$11137 | -$83333 | -$100000 | -$20.1M | -$18.8M | -$14.3M | -$1.4M |
| I+D | $27.6M | $984749 | $6.4M | $8.5M | $20.8M | $30.6M | $30.0M | $21.5M | $14.2M | $5.52B |
| Generales y Administrativos | $10.4M | $2.7M | $5.3M | $5.8M | $6.5M | $8.4M | $11.2M | $11.9M | $9.2M | $8.8M |
| Gastos Operativos | $37.9M | $3.7M | $11.7M | $14.3M | $27.3M | $39.0M | $11.2M | $12.1M | $9.2M | $12.1M |
| Beneficio Operativo | -$37.2M | -$11.2M | -$16.9M | -$14.3M | -$27.4M | -$39.1M | -$31.4M | -$30.9M | -$23.5M | -$13.6M |
| EBITDA | -$36.8M | -$11.2M | -$11.7M | -$14.3M | -$27.4M | -$38.7M | -$30.9M | -$30.7M | -$4.0M | -$10.4M |
| Gastos por Intereses | $2.2M | $322629 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $822709 |
| Beneficio Antes de Impuestos | -$39.3M | -$11.5M | -$16.7M | -$14.3M | -$27.4M | -$38.7M | -$30.9M | -$30.2M | -$4.1M | -$13.4M |
| Impuestos | $86000 | 0 | $10.2M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$39.3M | -$11.5M | -$16.7M | -$14.3M | -$27.4M | -$38.7M | -$30.9M | -$30.2M | -$4.1M | -$13.4M |
| BPA | $-30.02 | $-3.56 | $-30.16 | $-10.99 | $-10.93 | $-7.52 | $-4.39 | $-4.15 | $-0.48 | $-1.20 |
| BPA Diluido | $-30.02 | $-3.56 | $-30.16 | $-10.99 | $-10.93 | $-7.52 | $-4.39 | $-4.15 | $-0.48 | $-1.20 |
| Acciones en Circulación (Diluidas) | $1.3M | $269356 | $894368 | $1.3M | $2.5M | $5.1M | $7.0M | $7.3M | $8.5M | $111.8M |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $35.0M | $7.6M | $6.8M | $4.8M | $4.7M | $51.7M | $34.7M | $10.5M | $15.7M | $24.7M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cuentas por Cobrar | 0 | $284206 | $31037 | $555210 | $460168 | $1.1M | $1.7M | $949211 | $229982 | $573061 |
| Inventario | -$1.8M | $311571 | -$402.7M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $36.8M | $8.3M | $7.2M | $6.4M | $7.0M | $55.3M | $43.0M | $17.5M | $18.4M | $27.1M |
| Inmovilizado Material | $668000 | 0 | $9396 | $551811 | $277480 | $242714 | $522833 | $2.0M | $2.5M | $4.4M |
| Fondo de Comercio | 0 | $5.2M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $37.7M | $14.3M | $7.8M | $7.4M | $7.6M | $55.8M | $43.8M | $21.3M | $22.1M | $32.5M |
| Cuentas por Pagar | $1.4M | $308219 | $459705 | $1.1M | $1.0M | $2.1M | $2.0M | $3.4M | $1.5M | $1.2M |
| Deuda a Corto | $8.4M | 0 | 0 | 0 | $367285 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $16.9M | $966653 | $1.1M | $5.6M | $7.7M | $16.1M | $31.6M | $20.5M | $21.6M | $23.7M |
| Deuda a Largo | $4.4M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $24.6M | $967045 | $1.1M | $7.0M | $8.7M | $17.1M | $32.7M | $26.3M | $28.1M | $29.6M |
| Reservas | -$200.7M | -$12.2M | -$29.0M | -$44.0M | -$71.4M | -$110.1M | -$141.1M | -$171.2M | -$175.3M | -$188.7M |
| Patrimonio Neto | $13.1M | $13.3M | $6.7M | $440826 | -$1.2M | $38.8M | $11.1M | -$5.0M | -$6.0M | $2.8M |
| Deuda Total | $12.8M | 0 | 0 | $800452 | $756841 | $270546 | $488737 | $1.4M | $1.3M | $2.7M |
| Deuda Neta | -$22.1M | -$7.6M | -$6.8M | -$4.0M | -$3.9M | -$51.4M | -$34.2M | -$9.1M | -$14.4M | -$22.1M |
| Capital Circulante | $19.9M | $7.4M | $6.1M | $831526 | -$676689 | $39.2M | $11.4M | -$2.9M | -$3.2M | $3.4M |
Flujo de Caja (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Beneficio Neto | -$39.3M | -$11.5M | -$16.7M | -$14.3M | -$27.4M | -$38.7M | -$30.9M | -$30.2M | -$4.1M | -$13.4M |
| Amortizaciones | $261000 | 0 | $2440 | $11137 | $43227 | $26413 | $24202 | $38363 | $42325 | $2.2M |
| Compensación en Acciones | $2.8M | $15832 | $139348 | $462239 | $742031 | $1.6M | $2.2M | $2.5M | $2.2M | $1.5M |
| Cambio en Capital Circulante | -$2.3M | $1.1M | $634083 | $706191 | $1.5M | $8.7M | $10.7M | -$10.4M | $5.8M | -$210743 |
| Flujo de Caja Operativo | -$33.5M | -$2.5M | -$10.3M | -$13.3M | -$25.2M | -$28.8M | -$18.1M | -$38.9M | $5.4M | -$9.9M |
| Inversiones (CapEx) | -$535000 | 0 | -$11836 | 0 | -$17626 | -$14524 | -$63069 | -$629430 | -$573046 | -$385278 |
| Adquisiciones | 0 | $9.9M | -$507000 | $6.1M | 0 | 0 | 0 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$34.1M | -$2.5M | -$10.3M | -$13.3M | -$25.3M | -$28.8M | -$18.2M | -$39.5M | $4.8M | -$10.3M |
Crecimiento y Márgenes (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Crecimiento Ingresos (anual) | -100.0% | -71.9% | -99.7% | +10429.4% | ||||||
| Crecimiento Beneficio Neto (anual) | +70.7% | -45.5% | +14.8% | -92.1% | -41.2% | +20.0% | +2.5% | +86.6% | -230.6% | |
| Crecimiento BPA (anual) | +88.1% | -747.2% | +63.6% | +0.5% | +31.2% | +41.6% | +5.5% | +88.4% | -150.0% | |
| Cambio en Acciones (anual) | -79.4% | +232.0% | +45.1% | +93.2% | +103.2% | +38.3% | +3.2% | +16.8% | +1215.6% | |
| Crecimiento FCF (anual) | +92.5% | -304.7% | -29.5% | -89.6% | -14.0% | +36.9% | -117.5% | +112.2% | -313.0% | |
| Margen Bruto | 47.8% | -201.4% | -670.6% | -146110.2% | -137.5% | |||||
| Margen Operativo | -4850.4% | -313.9% | -1101.9% | -239692.2% | -1315.5% | |||||
| Margen EBITDA | -4805.1% | -309.2% | -1093.4% | -40998.3% | -1012.0% | |||||
| Margen Neto | -5131.2% | -309.5% | -1074.2% | -41430.9% | -1300.7% | |||||
| Margen FCF | -4447.9% | -181.5% | -1406.3% | 49276.4% | -997.0% | |||||
| Tasa Impositiva Efectiva | -0.2% | -0.0% | -61.1% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% |
Datos por Acción (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| FCF por Acción | $-26.02 | $-9.43 | $-11.49 | $-10.26 | $-10.07 | $-5.65 | $-2.58 | $-5.43 | $0.57 | $-0.09 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $1.3M | $269356 | $894367 | $1.3M | $2.5M | $5.1M | $7.0M | $7.3M | $8.5M | $111.8M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -748.08% |
| Rentabilidad sobre capital invertido | -179.10% |
| Rentabilidad sobre activos | -49.12% |
| Margen bruto | -89.45% |
| Margen operativo | -813.38% |
| Margen neto | -804.37% |
Salud financiera
| Deuda / Patrimonio | -12.08 |
| Ratio corriente | 0.99 |
Ratios Clave (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E | -2.83 | -7.29 | -0.28 | -0.90 | -1.47 | -3.19 | -2.27 | -0.95 | -6.50 | -1.61 |
| P/VC | 8.49 | 0.53 | 1.13 | 28.97 | -35.02 | 3.16 | 6.32 | -5.69 | -4.41 | 75.90 |
| P/V | 145.27 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 7.02 | 10.23 | 2709.59 | 209.43 |
| Margen Bruto | 47.8% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | -201.4% | -670.6% | -146110.2% | -137.5% |
| Margen Operativo | -4850.4% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | -313.9% | -1101.9% | -239692.2% | -1315.5% |
| Margen Neto | -5131.2% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | -309.5% | -1074.2% | -41430.9% | -1300.7% |
Empresas relacionadas: ADTX · AIMD · ANL · ASBP · ATHA · CTXR · FBLG
Explorar sector: Healthcare · Biotechnology
Más secciones de DARE: Resumen · Valoración · Estadísticas · Estimaciones · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones